<DOC>
	<DOCNO>NCT02087449</DOCNO>
	<brief_summary>Evaluate E1 wear , Clinical Performance E1 liner THA Korean Patient Population</brief_summary>
	<brief_title>Evaluate E1 Wear , Clinical Performance E1 Liner THA Korean Patient Population</brief_title>
	<detailed_description>Total hip arthroplasty ( THA ) one successful surgical procedure general . Yet , problem remain unsolved , aseptic loosening probably important . One main reason aseptic loosen THA foreign body reaction cause wear particle . Since late 1990s , orthopedic industry develop highly crosslinked polyethylene ( HXLPE ) material capitalize increased wear resistance . In 2007 , E1Â® Antioxidant Infused Technology develop reduce wear rate , maintain mechanical property prevent oxidative degradation .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Legg-Calve-Perthes Disease</mesh_term>
	<criteria>Patients include study receive Ringloc acetabular system E1 liner per approve indication use KFDA Korea . Specifically , 1 . Osteoarthritis 2 . Avascular necrosis 3 . Legg Perthes 4 . Rheumatoid Arthritis 5 . Diastrophic variant 6 . Fracture pelvis 7 . Fused hip 8 . Slipped capital epiphysis 9 . Subcapital fracture 10 . Traumatic arthritis Patients age 20 Patients limited comorbidity ASA I III Exclusion Criteria study comply state contraindication package insert Ringloc acetabular system E1 liner . These indication state : Absolute contraindication include : infection , sepsis , osteomyelitis Relative contraindication include : 1. uncooperative patient patient neurologic disorder incapable follow direction , 2. osteoporosis , 3. metabolic disorder may impair bone formation , 4. osteomalacia , 5. distant focus infection may spread implant site , 6. rapid joint destruction , mark bone loss bone resorption apparent roentgenogram , 7. vascular insufficiency , muscular atrophy , neuromuscular disease . 8. pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>